 Chemoembolization, Therapeutic
"Chemoembolization, Therapeutic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm.
| Descriptor ID |
D016461
|
| MeSH Number(s) |
E02.520.360.150 E02.926.500.150
|
| Concept/Terms |
Chemoembolization, Therapeutic- Chemoembolization, Therapeutic
- Therapeutic Chemoembolization
- Chemoembolizations, Therapeutic
- Therapeutic Chemoembolizations
|
Below are MeSH descriptors whose meaning is more general than "Chemoembolization, Therapeutic".
Below are MeSH descriptors whose meaning is more specific than "Chemoembolization, Therapeutic".
This graph shows the total number of publications written about "Chemoembolization, Therapeutic" by people in this website by year, and whether "Chemoembolization, Therapeutic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 1 | 1 | 2 | | 2005 | 1 | 0 | 1 | | 2006 | 2 | 0 | 2 | | 2007 | 3 | 1 | 4 | | 2008 | 8 | 0 | 8 | | 2009 | 6 | 1 | 7 | | 2010 | 3 | 1 | 4 | | 2011 | 5 | 0 | 5 | | 2012 | 9 | 1 | 10 | | 2013 | 6 | 0 | 6 | | 2014 | 6 | 0 | 6 | | 2015 | 4 | 1 | 5 | | 2016 | 3 | 0 | 3 | | 2018 | 4 | 0 | 4 | | 2019 | 2 | 1 | 3 | | 2020 | 4 | 0 | 4 | | 2021 | 3 | 0 | 3 | | 2022 | 1 | 0 | 1 | | 2023 | 2 | 0 | 2 | | 2024 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Chemoembolization, Therapeutic" by people in Profiles.
-
Zandieh G, Yazdaninia I, Afyouni S, Shaghaghi M, Borhani A, Mohseni A, Shaghaghi S, Liddell R, Kamel IR. Spectrum of Imaging Findings and Complications After Hepatic Transarterial Chemoembolization for Liver Tumors. J Comput Assist Tomogr. 2024 Sep-Oct 01; 48(5):701-712.
-
Mendiratta-Lala M, Aslam A, Bai HX, Chapiro J, De Baere T, Miyayama S, Chernyak V, Matsui O, Vilgrain V, Fidelman N. Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization. Eur Radiol. 2024 May; 34(5):3284-3297.
-
Hsieh C, Laguna A, Ikeda I, Maxwell AWP, Chapiro J, Nadolski G, Jiao Z, Bai HX. Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma. Radiology. 2023 11; 309(2):e222891.
-
Hazhirkarzar B, Shaghaghi M, Baghdadi A, Ghadimi M, Ghasabeh MA, Wu Q, Tang H, Khoshpouri P, Ameli S, Habibabadi RR, Motaghi M, Meyer CF, Kamel IR. Can Posttransarterial Chemoembolization Volumetric Oil Deposition on Computed Tomography Predict Treatment Response on Magnetic Resonance Imaging in Leiomyosarcoma Metastases to the Liver? J Comput Assist Tomogr. 2022 May-Jun 01; 46(3):327-332.
-
Tai D, Loke K, Gogna A, Kaya NA, Tan SH, Hennedige T, Ng D, Irani F, Lee J, Lim JQ, Too CW, Ng MCH, Tham CK, Lam J, Koo SL, Chong HS, Goh GB, Huang HL, Venkatanarasimha N, Lo R, Chow PKH, Goh BKP, Chung A, Toh HC, Thng CH, Lim TKH, Yeong J, Zhai W, Chan CY, Choo SP. Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial. Lancet Gastroenterol Hepatol. 2021 12; 6(12):1025-1035.
-
Hazhirkarzar B, Tang H, Ghadimi M, Baghdadi A, Motaghi M, Wu Q, Shaghaghi M, Kamel I. Predicting early necrosis of colorectal liver metastases using volumetric enhancement on baseline MRI and oil deposition on post-cTACE unenhanced CT. Abdom Radiol (NY). 2021 10; 46(10):4610-4618.
-
Trivedi P. Cost-Effectiveness of Tumor Response Criteria After Chemoembolization for Hepatocellular Carcinoma: Working Harder May Be Worth It. J Am Coll Radiol. 2021 07; 18(7):935-936.
-
Shaghaghi M, AliyariG Hasabeh M, Ameli S, Ghadimi M, Hazhirkarzar B, Rezvani Habibabadi R, Tang H, Khoshpouri P, Wu Q, Pandey A, Pandey P, Baghdadi A, Kamel IR. Role of tumor margin and ADC change in defining the need for additional treatments after the first TACE in patients with unresectable HCC. Eur J Radiol. 2020 Dec; 133:109389.
-
Karanicolas P, Beecroft JR, Cosby R, David E, Kalyvas M, Kennedy E, Sapisochin G, Wong R, Zbuk K. Regional Therapies for Colorectal Liver Metastases: Systematic Review and Clinical Practice Guideline. Clin Colorectal Cancer. 2021 03; 20(1):20-28.
-
Shaghaghi M, Aliyari Ghasabeh M, Ameli S, Ghadimi M, Hazhirkarzar B, Rezvani Habibabadi R, Khoshpouri P, Pandey A, Pandey P, Kamel IR. Post-TACE changes in ADC histogram predict overall and transplant-free survival in patients with well-defined HCC: a retrospective cohort with up to 10 years follow-up. Eur Radiol. 2021 Mar; 31(3):1378-1390.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|